Robust cost efficacy of a novel, validated screening test at 12–20 Weeks gestation for the prediction of preterm birth (PTB) at or before 32 Weeks in singletons
Robust cost efficacy of a novel, validated screening test at 12–20 Weeks gestation for the prediction of preterm birth (PTB) at or before 32 Weeks in singletons